Clinical trial
Breast Cancer Treated by Neoadjuvant Chemotherapy
NCT00425516 · Centre Jean Perrin, Other · Completed
Key facts
| NCT number | NCT00425516 |
|---|---|
| Title | Breast Cancer Treated by Neoadjuvant Chemotherapy |
| Official title | Clinical Trial of the Neoadjuvant Standard Chemotherapy 3 FEC 100 + 3 TAXOTERE Protocol Versus the Same Protocol Adapted as a Function of Clinical Response |
| Lead sponsor | Centre Jean Perrin, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Individualized Chemotherapy |
| Intervention type | Drug |
| Interventions | Taxotere, 5-Fluorouracil, Epirubicin, Cyclophosphamide |
| Enrollment | 264 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2014 |
| Completion | Aug 1, 2014 |
| First posted | Jan 23, 2007 |
| Last update posted | Oct 1, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: